Genmab A/S (GMAB)
NASDAQ:GMAB
Holding GMAB?
Track your performance easily

Genmab (GMAB) Stock Investors

510 Followers
Based on 757,311 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GMAB
On average, investors allocate 3.26% of their portfolios to GMAB
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 757,311 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GMAB

3.2%
Last 7
Days
2.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GMAB, out of 757,311 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GMAB Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.55%
$25.48
Opened
0.26%
$26.93
Based on the activity of 14,468 investors who made their portfolios public
The table shows changes in GMAB in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GMAB Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Enphase Energy
5.04%
-1.63%
-4.99%
16.05B
Technology
Block
4.21%
-1.17%
-2.73%
41.45B
Technology
Bristol-Myers Squibb
3.44%
-1.33%
-2.60%
100.34B
Healthcare
Trade Desk
4.84%
-1.57%
-1.99%
51.77B
Technology
DraftKings
5.58%
-1.48%
+0.87%
34.22B
Consumer Cyclical
ServiceNow
4.06%
-1.47%
-1.03%
182.48B
Technology
Merck & Company
3.78%
-0.86%
+1.11%
299.84B
Healthcare
Zscaler
3.70%
-1.20%
+2.19%
25.97B
Technology
Cisco Systems
4.43%
-1.34%
-0.27%
201.97B
Technology
PDD Holdings
4.86%
-1.04%
+6.61%
136.63B
Consumer Cyclical
Based on the activity of 757,311 active portfolios
Open your Smart Portfolio

GMAB Investor Analysis

GMAB investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.8%
of GMAB holders
are under 35
Average Segment Performance
Average P/E Ratio20.16
Beta8.32
Dividend Yield3.50%
GMAB investors between 35–55

Between 35–55

12.7%
Last 30 days
Holdings Change
39.1%
of GMAB holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.25
Beta13.76
Dividend Yield3.65%
GMAB investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
53.0%
of GMAB holders
are over 55
Average Segment Performance
Average P/E Ratio20.06
Beta4.95
Dividend Yield3.36%
Overview of age group and performance of GMAB stock investors
See who invests in GMAB according to age group and performance.

FAQ

How many retail Investors hold GMAB?
<0.1% of TipRanks' retail investors hold GMAB in their portfolios.
    What is GMAB Investor Sentiment?
    GMAB’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of GMAB in the last 7 days?
      ▼ 3.2% of TipRanks' retail investors changed their holding of GMAB in the last 7 days.
        What percentage of retail investors changed their holding of GMAB in the last 30 days?
        ▲ 2.8% of TipRanks' retail investors changed their holding of GMAB in the last 30 days.
          What is the average age of retail investors who hold GMAB?
          The average age of GMAB Holders is over 55.
            What other stocks have GMAB investors also bought?
            GMAB Investors also bought ENPH, SQ, BMY, TTD, DKNG, NOW, MRK, ZS, CSCO, PDD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CPRXCatalyst Pharma
              EXELExelixis
              AVDLAvadel Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis